아이언우드 제약 (IRWD)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

아이언우드 제약 Stock (IRWD) Company Profile

Ironwood Pharmaceuticals Inc

Healthcare (1096)

617-621-7722

100 SUMMER STREET, SUITE 2300, BOSTON, MA

@ironwoodpharma

최신 SEC 제출 서류

IRWD's Discussions on Twitter

Compare IRWD vs TAK, HLN, TEVA, ZTS, UTHR

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
IRWD Ironwood Pharmaceuticals Inc	4.47	735.82M	361.51M	102.18M	112.21M	0.5974
TAK Takeda Pharmaceutical Co Adr	16.56	52.88B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.76	42.98B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	32.95	38.37B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.56	31.68B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	547.06	23.22B	3.17B	1.29B	1.01B	27.09

아이언우드 제약 Stock (IRWD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-01-05	업그레이드	Citizens JMP	Mkt Perform → Mkt Outperform
2025-04-15	다운그레이드	Jefferies	Buy → Hold
2025-04-15	다운그레이드	Wells Fargo	Overweight → Equal Weight
2025-04-14	다운그레이드	Citizens JMP	Mkt Outperform → Mkt Perform
2024-09-09	개시	Leerink Partners	Market Perform
2024-08-08	다운그레이드	CapitalOne	Overweight → Equal Weight
2024-01-17	개시	Craig Hallum	Buy
2023-12-14	개시	Wells Fargo	Overweight
2023-11-09	개시	Jefferies	Buy
2023-09-28	개시	JMP Securities	Mkt Outperform
2022-09-02	개시	CapitalOne	Overweight
2022-04-22	개시	Piper Sandler	Overweight
2020-09-30	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-06-17	개시	Northland Capital	Outperform
2019-07-10	재개	Credit Suisse	Neutral
2019-03-27	업그레이드	Morgan Stanley	Underweight → Equal-Weight
2019-02-25	업그레이드	H.C. Wainwright	Sell → Neutral
2019-01-24	업그레이드	JP Morgan	Underweight → Neutral
2018-11-07	다운그레이드	Credit Suisse	Outperform → Neutral
2018-11-07	다운그레이드	JP Morgan	Neutral → Underweight
2018-07-23	개시	H.C. Wainwright	Sell
2018-05-09	다운그레이드	Morgan Stanley	Equal-Weight → Underweight
2018-01-05	다운그레이드	BofA/Merrill	Buy → Underperform
2017-12-06	다운그레이드	Mizuho	Buy → Neutral
2017-07-21	다운그레이드	JP Morgan	Overweight → Neutral
2017-05-03	개시	Wells Fargo	Outperform
2017-04-07	재확인	Mizuho	Buy
2017-02-22	재확인	Barclays	Equal Weight
2016-11-04	재확인	Mizuho	Buy
2016-10-24	재확인	Wedbush	Neutral
2016-10-10	재확인	Mizuho	Buy
2016-09-27	재확인	WallachBeth	Hold

아이언우드 제약 주식(IRWD)의 최신 뉴스

아이언우드 제약 (IRWD) 재무 분석

아이언우드 제약 (IRWD)

아이언우드 제약 Stock (IRWD) Company Profile

Compare IRWD vs TAK, HLN, TEVA, ZTS, UTHR

아이언우드 제약 Stock (IRWD) Upgrades & Downgrades

아이언우드 제약 주식(IRWD)의 최신 뉴스

Insider Sell Alert: Ronald Silver Sells Shares of Ironwood Pharm - GuruFocus

Form 4 Ironwood Pharmaceuticals Inc For: 9 July By Investing.com - Investing.com Nigeria

Ironwood Pharmaceuticals (IRWD) Declines 2.1% as Stock Approaches Key Support LevelNHNL Ratio - dars.gov.et

Ronald Silver, PFO, sells $578k in Ironwood Pharma stock - Investing.com

Ronald Silver, PFO, sells $578k in Ironwood Pharma stock By Investing.com - Investing.com India

Ironwood (IRWD) finance chief sells 127,890 shares in 10b5-1 stock plan - Stock Titan

Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (NASDAQ:IRWD) - TradingView

Form 144 IRONWOOD PHARMACEUTICALS For: 7 July By Investing.com - Investing.com Nigeria

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Proposed Common stock sale for IRWD (NASDAQ: IRWD) via Morgan Stanley Smith Barney - Stock Titan

Price to earnings forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView

Price to sales forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView

Ironwood Pharmaceuticals stock follows its own business case. IRWD trades on Nasdaq. - ad-hoc-news.de

​Ironwood Pharmaceuticals (IRWD) Gains From Strong Fiscal Q1 2026 Earnings Momentum - Yahoo Finance

Price to book forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView

IRWD Forecast — Price Target — Prediction for 2027 - TradingView

Gastroparesis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda - Barchart.com

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail

Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (BX:I76) - TradingView

Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (SWB:I76) - TradingView

Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (MUN:I76) - TradingView

I76 Forecast — Price Target — Prediction for 2027 - TradingView

5 Small Drug Stocks to Invest in Amid a Biotech Comeback - Yahoo Finance

Ironwood Pharmaceuticals (IRWD) Short Interest & Short Float | Updated Jun 2026 - MarketBeat

Ironwood Pharmaceuticals Inc (IRWD) Valuation: PE, PB & Fair Value Analysis - TradingKey

Ironwood Pharmaceuticals StockAnalyst snapshot and sector review at week’s end - AD HOC NEWS

IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill

Ironwood Pharmaceuticals (IRWD) adds 10M shares to 2019 equity incentive plan - Stock Titan

Ironwood Pharmaceuticals Inc (IRWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Ironwood Pharmaceuticals Inc - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Institutional Confidence - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Ironwood Pharmaceuticals Inc (IRWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Director Julie Mchugh Sells 21,571 Shares of Ironwood Pharmaceuticals Inc (IRWD) - GuruFocus

Ironwood Pharmaceuticals Inc (IRWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Ironwood (IRWD) director Jay Shepard receives 63,481-share restricted stock grant - Stock Titan

Ironwood (NASDAQ: IRWD) director awarded restricted stock that vests before next meeting - Stock Titan

Ironwood (IRWD) director Marla Kessler receives 63,481-share restricted stock grant - Stock Titan

Ironwood Pharmaceuticals (IRWD) director receives 63,481-share grant - Stock Titan

Ironwood Pharmaceuticals (IRWD) director granted 63,481 restricted shares in latest Form 4 - Stock Titan

Ironwood (NASDAQ: IRWD) director sells shares and receives new stock grant - Stock Titan

Director Catherine Moukheibir receives 63,481 Ironwood (IRWD) restricted shares - Stock Titan

[144] IRONWOOD PHARMACEUTICALS INC SEC Filing - Stock Titan

Ironwood Pharmaceuticals (IRWD) Jefferies London Healthcare Conference 2024 Summary - Quartr

Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026 - TradingView

Ironwood Pharmaceuticals (IRWD) retires $200M 2026 convertible notes in cash - Stock Titan

ZVRA Stock Price and Chart — NASDAQ:ZVRA - TradingView

Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates - MSN

Ironwood Pharmaceuticals (IRWD) Tops Healthcare Sector with Stro - GuruFocus

아이언우드 제약 (IRWD) 재무 분석

매출

순이익

현금흐름

주당 순 이익

IRWD과 유사한 종목

Ironwood Pharmaceuticals (IRWD) Gains From Strong Fiscal Q1 2026 Earnings Momentum - Yahoo Finance